|
BioScreening - organic compounds for screening
News: Grants and AwardsUniversity of California, San Francisco, Researcher Receives ASBMB-Merck Award - Bethesda, MD, December 12, 2009 –(PR.com)– James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his [...]
Professor Receives Grant to Develop More Rapid Technology For Screening Blood Samples - AUSTIN, Texas — Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.
Biomarkers are small molecules that indicate the presence of a particular physiological condition, typically [...]
Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds: NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition - Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds: NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition
PRNewswire - October 28, 2009
CARY, N.C. and BIRMINGHAM, Ala., Oct. 28 /PRNewswire-USNewswire/ — Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract research organization conducting [...]
DiscoveryBioMed Awarded $300,000 NIH Grant for Cystic Fibrosis Drug Research and Development - BIRMINGHAM, Ala. - (Business Wire) DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The $308,000 grant will be used to advance certain small molecule drug discovery programs designed to correct the genetic mutation most common to cystic [...]
Scripps Researchers Win $3.9M NIH Grant for Protein Ligand Screening Tech - NEW YORK (GenomeWeb News) – A pair of researchers from the Scripps Research Institute have been awarded a five-year, $3.9 million grant from the National Institutes of Health to develop a protein ligand screening technology.
The grant, awarded through NIH’s recently introduced Roadmap Transformative grant program, will be shared by the laboratories of Tom Kodadek, a [...]
ERGONEX Pharma receives Frost & Sullivan’s European Orphan Diseases Entrepreneurial Company Award 2009 - Appenzell, Switzerland, October 19, 2009 / b3c newswire / - ERGONEX Pharma received one of the prestigious ‘European Orphan Diseases Entrepreneurial Company Award’ on the occasion of Frost & Sullivan’s ‘2009 Excellence in Healthcare Awards Banquet,’ held in London on 8th October 2009. The highly competitive award was presented to [...]
Scripps Research scientists awarded $3.9 million grant to develop new compound screening platform - Bicoastal effort could help revolutionize the search for new therapies
La Jolla, CA, and Jupiter, FL, October 5, 2009 –A pair of scientists from The Scripps Research Institute, one on each coast, has been awarded a five-year $3.9 million grant from the National Institutes of Health (NIH) to develop a new technology to accelerate the search [...]
BioLeap Wins GlaxoSmithKline Contract to Design Novel Lead Compounds for Previously Intractable Targets for Important Unmet Medical Needs. - BioLeap and GSK have entered into an agreement whereby BioLeap will design novel
lead compounds for "difficult" drug targets. The targets (not disclosed) are
ones for which conventional approaches, like high throughput screening, have
failed to yield a viable chemical starting point. Typically these are in areas
of high unmet medical need.
BioLeap will use its computational fragment-based drug design [...]
Southern Research to Play Key Role in the Federal Government’s Search for New Cancer Therapies - National Cancer Institute Chemical Biology Consortium to coordinate academic, private and government cancer drug discovery efforts
BIRMINGHAM, Ala., Aug. 20 /PRNewswire-USNewswire/ — Southern Research Institute today announced that it has been selected as one of 11 organizations to help establish the National Cancer Institute’s (NCI) Chemical Biology Consortium (CBC)–a program meant to coordinate and accelerate the [...]
Vanderbilt Joins National Consortium to Develop New Cancer Therapies - Vanderbilt University has been selected as one of 10 centers in the nation to participate in the Chemical Biology Consortium (CBC), a major new initiative to facilitate the discovery and development of new agents to treat cancer.
As one of four Chemical Diversity Centers, Vanderbilt’s role in the consortium will be to synthesize and optimize new [...]
National Cancer Institute names Emory to nationwide NCI chemical biology consortium - CBC will support rapid development of innovative, targeted cancer therapies
Emory University’s Chemical Biology Discovery Center has been selected by SAIC-Frederick, Inc. (SAIC-F) to be part of an 11-member national consortium aimed at accelerating the discovery and development of new and innovative, targeted cancer therapies. SAIC-F is the prime contractor to the National Cancer Institute at [...]
Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer’s Disease - Start-up company continues momentum with selection of disease-modifying small molecule drug leads for behavioral testing
PITTSBURGH, July 16 /PRNewswire/ — Cognition Therapeutics Inc., a Pittsburgh-based drug discovery company developing small molecule disease-modifying treatments for Alzheimer’s, has closed on a $1.21M Series A financing. The round was led by Ogden CAP, LLC of New York City and [...]
CLC bio’s enterprise platform wins award at Bio-IT World Expo in Boston - Boston, Massachusetts, USA — April 30, 2009 — CLC bio’s enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has just been awarded the “Best of Show” prize at the Bio-IT World Conference & Expo 2009 - an award judged by a team of Bio-IT World magazine editors and [...]
Nanion nominated for The German Industry’s Innovation Award - Munich, Germany, Jan 20th, 2009; Nanion is again nominated for a prestigious
innovation award, due its impressive product portfolio of automated patch clamp
systems. More than 350 companies competed in this year’s Innovation Award and
Nanion is finalist in the category “Start-Up Companies”.
The German Industry’s Innovation Award, also the world’s first innovation award, has since 1980 annually nominated [...]
Profiling of Tumor Tissue Slices is Awarded Prize - Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest
Rostock, Germany, November 26, 2007 / b3c newswire / - Bionas GmbH, a specialist for in vitro profiling the metabolic activity of cells, announced that Prof. Pedro Mestres of the Saarland University (Homburg/Saar, Germany) has been awarded [...]
ERA-NET PathoGenoMics recognises outstanding PhD theses - Increasingly, disease-causing microorganisms are being analysed on a genetic level in the hope of identifying critical factors that might be therapeutically applicable. European research in this area is being promoted under the roof of the ERA-NET PathoGenoMics network. During the 3rd European Conference on Procaryotic Genomics, held from 7 to 10 October in Göttingen, Germany, [...]
FDA approves Merck’s Isentress for HIV - Oct 16, 2007 (Datamonitor via COMTEX) — MRK | charts | news | PowerRating — The FDA has granted Merck & Co.’s Isentress tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to [...]
Nanion’s Technology Nominated for Presidential Innovation Award - Munich , Oct 11, 2007 : The planar patch clamp technology used in a family of automated electrophysiology products developed and marketed by Nanion Technologies GmbH in Munich , Germany , is among four technological and scientific innovations that have been nominated for this year’s Deutscher Zukunftspreis (German Future Award). The nomination of the project [...]
Portrait™ 630 Reagent Multi-spotter Wins Technology Prize at MipTec 10th Anniversary Conference in Basel, Switzerland - Sunnyvale, CA, May 22, 2007 - Portrait™ 630 Reagent Multi-spotter Wins Technology Prize at MipTec 10th Anniversary Conference in Basel, Switzerland
The European Laboratory Robotics Interest Group (ELRIG) has selected the Labcyte Portrait 630 reagent multi-spotter as the winner of its annual Technology Prize, awarded this year at the MipTec 10th Anniversary Conference, held May 8-11, [...]
KU Medical Center to lead $7.5-million male contraceptive research and drug development program - A researcher at the University of Kansas Medical Center has been awarded more than $7.5 million in funding from the National Institutes of Health to lead a team, including researchers at seven universities, in a collaborative effort to develop male contraceptives.
This five-year grant will establish the Interdisciplinary Center for Male Contraceptive Research and Drug [...]
|
|
